Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

SUPPRESSA, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 218
EU - Europa 116
NA - Nord America 73
SA - Sud America 3
AF - Africa 1
Totale 411
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 176
US - Stati Uniti d'America 68
FI - Finlandia 66
HK - Hong Kong 19
IT - Italia 17
FR - Francia 6
DE - Germania 5
NL - Olanda 5
IN - India 4
LV - Lettonia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
NO - Norvegia 3
CA - Canada 2
CN - Cina 2
CY - Cipro 2
GB - Regno Unito 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
PA - Panama 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
CO - Colombia 1
EE - Estonia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RU - Federazione Russa 1
SE - Svezia 1
TH - Thailandia 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 411
Salva come PNG Salva come JPEG
Città #
Singapore 134
Helsinki 66
Hong Kong 19
Los Angeles 7
Paris 5
Riga 4
Rome 4
Santa Clara 3
Boston 2
Boydton 2
Colombo 2
Dubai 2
Foggia 2
Nicosia 2
Oslo 2
Slough 2
Verona 2
Vientiane 2
Ashburn 1
Baku 1
Bogotá 1
Buenos Aires 1
Dublin 1
Düsseldorf 1
Florence 1
Haifa 1
Islamabad 1
Lima 1
Lisbon 1
Manila 1
Montreal 1
New York 1
Newark 1
Pune 1
Stockholm 1
Tallinn 1
Tashkent 1
Toronto 1
Vienna 1
Yerevan 1
Totale 284
Salva come PNG Salva come JPEG
Nome #
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 36
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 35
Antibiotic use and associated factors in a large sample of hospitalised older people 8
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 7
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 7
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 6
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 6
Pain and Frailty in Hospitalized Older Adults 6
Neuroimmune activation in chronic heart failure 6
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children 5
Identification of a Novel Score for Adherence to the Mediterranean Diet That Is Inversely Associated with Visceral Adiposity and Cardiovascular Risk: The Chrono Med Diet Score (CMDS) 5
Manifestazioni cliniche in un'ampia coorte di pazienti pediatrici affetti da Teleangiectasia Emorragica Ereditaria 5
The arduous challenge of seeking for biomarkers in rare diseases 5
Hereditary Hemorrhagic Telangiectasia: a 15-year shorter life span 5
HHT: A rare disease with a broad spectrum of clinical aspects 5
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 5
Studio longitudinale dell'evoluzione in età evolutiva delle malformazioni arterovenoso nella teleangiectasia emorragica ereditaria 4
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network 4
Impact of electronic cigarettes (e-cigs) and heat-not-burn/heated tobacco products (HnB/HTP) on asthma and chronic obstructive pulmonary disease: a viewpoint of the Italian Society of Internal Medicine 4
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 4
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation 4
Orofacial hereditary haemorrhagic telangiectasia: High power diode laser in early and advanced lesion treatment 4
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 4
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 4
Improvement of the diagnostic accuracy of liver shunts in Hereditary Hemorrhagic Telangiectasia 4
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 4
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 4
Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial 4
HHT: a rare disease with broad spectrum of clinical aspects 4
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study 4
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 4
Another case of diagnostic delay brings about a serious brain abscess with complex clinical management 4
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 4
13C-methacetin breath test: A new tool to predict the presence of liver vascular malformations in patients with hereditary haemorragic teleangiectasia 4
Association of fT4 and TSH with insulin resistance in aged obese euthyroid people 4
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT). 4
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 4
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 4
Multi-Slice-CT vs dynamic time-resolved MR-Angiography for evaluation of hepatic involvement in Hereditary Hemorrhagic Telangiectasia 4
A low prevalence of clinical manifestations conceals a much more frequent liver involvement in hereditary hemorrhagic telangiectasia (HHT) 4
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 4
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 4
New insight into allergic diseases in the elderly 4
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 4
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 4
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 4
Caratterizzazione molecolare dei geni ENG ed ALK 1 nella popolazione italiana mediante analisi DHPLC 3
Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis 3
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 3
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)? 3
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 3
Life expectancy in patients with heredetary haemorrhagic teleangectasia 3
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 3
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 3
Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings 3
Cardiovascular risk in rare diseases: a prognostic stratification model in a cohort of sarcoidosis patients 3
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 3
What changed in the Italian internal medicine and geriatric wards during the lockdown 3
C’è ancora una differenza di genere nell’arteriopatia periferica (AOP)? 3
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 3
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 3
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 3
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 3
Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia (vol 152, pg 365, 2010) 3
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 3
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study 3
The impact of Mediterranean diet on myocardial infarction in southern Italy age population 3
Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia 3
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 3
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 3
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 3
Effects of VEGF on Phenotypic Severity in Children With Hereditary Hemorrhagic Telangiectasia 3
Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series 3
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia 3
Longitudinal study of natural history of arteriovenous malformations in evolutionary age of Hereditary Haemorrhagic Telangiectasia 3
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 3
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 3
Improvement of the diagnostic accuracy of the liver shunts in hereditary hemorrhagic teleangiectasia 3
Phenotyping congestion in patients with acutely decompensated heart failure with preserved and reduced ejection fraction: The Decongestion duRing therapY for acute decOmpensated heart failure in HFpEF vs HFrEF-DRY-OFF study 3
Emergencies in hereditary hemorrhagic telangiectasia 3
MONITORING DATA DURING AND AFTER PREGNANCY TO EARLY DETECT RARE DISEASES: THE EDERA PROJECT 3
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 3
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 3
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 3
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 3
Vascern HHT survey 2: drug registry-part 1 3
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 3
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 3
Liver involvement associated to hereditary haemmorrhagic telangiectasia in pediatric age 3
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician 3
Pulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia 3
Hereditary Hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers 3
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 3
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia 3
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 3
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 3
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 3
CLINICAL PHENOTYPING IN SARCOIDOSIS MANAGEMENT 3
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 3
Diet and myocardial infarction: A nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 3
Totale 434
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.055
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025693 0 0 0 367 74 252 0 0 0 0 0 0
Totale 693